Bertine M. J. Flokstra – de Blok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bertine M. J. Flokstra – de Blok has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Janwillem Kocks
General Practitioners Research Institute, Groningen, the Netherlands
4 shared publications- Janwillem W. H. Kocks
General Practitioners Research Institute
4 shared publications Thys van der Molen
General Practitioners Research Institute, Groningen, the Netherlands
4 shared publications- Anthony E. J. Dubois
University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands
3 shared publications - Dermot Ryan
Usher Institute University of Edinburgh Edinburgh UK
3 shared publications Ellen van Heijst
GRIAC Research Institute University of Groningen University Medical Center Groningen Groningen The Netherlands
3 shared publications
Latest Publications
- 1 January 2023
- Published by Springer Nature
- p. 2552-2554
Food Allergy Quality of Life Questionnaires (FAQLQ)
- 1 January 2023
- Published by Springer Nature
- p. 2552-2554
Food Allergy Quality of Life Questionnaires (FAQLQ)
- Open Access
- 14 December 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (3) , 2200558
Development of a tool to detect small airways dysfunction in asthma clinical practice
Background: Small airways dysfunction (SAD) in asthma is difficult to measure and a gold standard is lacking. The aim of this study was to develop a simple tool including items of the Small Airways Dysfunction Tool (SADT) questionnaire, basic patient characteristics and respiratory tests available depending on the clinical setting to predict SAD in asthma.Methods: This study was based on the data of the multinational ATLANTIS (Assessment of Small Airways Involvement in Asthma) study including the earlier developed SADT questionnaire. Key SADT items together with clinical information were now used to build logistic regression models to predict SAD group (less likely or more likely to have SAD). Diagnostic ability of the models was expressed as area under the receiver operating characteristic curve (AUC) and positive likelihood ratio (LR+).Results: SADT item 8, “I sometimes wheeze when I am sitting or lying quietly”, and the patient characteristics age, age at asthma diagnosis and body mass index could reasonably well detect SAD (AUC 0.74, LR+ 2.3). The diagnostic ability increased by adding spirometry (percentage predicted forced expiratory volume in 1 s: AUC 0.87, LR+ 5.0) and oscillometry (resistance difference between 5 and 20 Hz and reactance area: AUC 0.96, LR+ 12.8).Conclusions: If access to respiratory tests is limited (e.g.primary care in many countries), patients with SAD could reasonably well be identified by asking about wheezing at rest and a few patient characteristics. In (advanced) hospital settings patients with SAD could be identified with considerably higher accuracy using spirometry and oscillometry.
- 14 December 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (3) , 2200558
Open AccessDevelopment of a tool to detect small airways dysfunction in asthma clinical practice
Background: Small airways dysfunction (SAD) in asthma is difficult to measure and a gold standard is lacking. The aim of this study was to develop a simple tool including items of the Small Airways Dysfunction Tool (SADT) questionnaire, basic patient characteristics and respiratory tests available depending on the clinical setting to predict SAD in asthma.Methods: This study was based on the data of the multinational ATLANTIS (Assessment of Small Airways Involvement in Asthma) study including the earlier developed SADT questionnaire. Key SADT items together with clinical information were now used to build logistic regression models to predict SAD group (less likely or more likely to have SAD). Diagnostic ability of the models was expressed as area under the receiver operating characteristic curve (AUC) and positive likelihood ratio (LR+).Results: SADT item 8, “I sometimes wheeze when I am sitting or lying quietly”, and the patient characteristics age, age at asthma diagnosis and body mass index could reasonably well detect SAD (AUC 0.74, LR+ 2.3). The diagnostic ability increased by adding spirometry (percentage predicted forced expiratory volume in 1 s: AUC 0.87, LR+ 5.0) and oscillometry (resistance difference between 5 and 20 Hz and reactance area: AUC 0.96, LR+ 12.8).Conclusions: If access to respiratory tests is limited (e.g.primary care in many countries), patients with SAD could reasonably well be identified by asking about wheezing at rest and a few patient characteristics. In (advanced) hospital settings patients with SAD could be identified with considerably higher accuracy using spirometry and oscillometry.
- Open Access
- 27 April 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (9) , 2312-2323.e2
Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study
- 27 April 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (9) , 2312-2323.e2
Open AccessPerceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study
- Open Access
Allergic and hypersensitivity conditions in non‐specialist care: Flow diagrams to support clinical practice
Most patients presenting with allergies are first seen by primary care health professionals. The perceived knowledge gaps and educational needs were recently assessed in response to which the LOGOGRAM Task Force was established with the remit of constructing pragmatic flow diagrams for common allergic conditions in line with an earlier EAACI proposal to develop simplified pathways for the diagnosis and management of allergic diseases in primary care. To address the lack of accessible and pragmatic guidance, we designed flow diagrams for five major clinical allergy conditions: asthma, anaphylaxis, food allergy, drug allergy, and urticaria. Existing established allergy guidelines were collected and iteratively distilled to produce five pragmatic and accessible tools to aid diagnosis and management of these common allergic problems. Ultimately, they should now be validated prospectively in primary care settings.
Open AccessAllergic and hypersensitivity conditions in non‐specialist care: Flow diagrams to support clinical practice
Most patients presenting with allergies are first seen by primary care health professionals. The perceived knowledge gaps and educational needs were recently assessed in response to which the LOGOGRAM Task Force was established with the remit of constructing pragmatic flow diagrams for common allergic conditions in line with an earlier EAACI proposal to develop simplified pathways for the diagnosis and management of allergic diseases in primary care. To address the lack of accessible and pragmatic guidance, we designed flow diagrams for five major clinical allergy conditions: asthma, anaphylaxis, food allergy, drug allergy, and urticaria. Existing established allergy guidelines were collected and iteratively distilled to produce five pragmatic and accessible tools to aid diagnosis and management of these common allergic problems. Ultimately, they should now be validated prospectively in primary care settings.
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
The aim of this survey was to explore the specific educational needs of a cohort of European GPs with regards to allergy training so that future educational initiatives may better support the delivery of allergy services in primary care. Method This study took the form of a cross-sectional observational study in which a structured electronic questionnaire was distributed to primary care providers, in eight languages, across 8 European countries between September 2019 and November 2019. Data associated with demographic parameters, professional qualifications, type of employment, level of confidence regarding competencies for diagnosis and treatment of allergic diseases, referral of patients to allergist and preferred method of learning and assessment were collected. A 5-point Likert scale was used to assess level of confidence. Exploratory analysis was carried out. Results A total of 687 responses were available for analysis, with 99.3% of responders working within Europe. 70.1% of participants were female; and 48.0% and 48.0% of participants respectively had received some undergraduate and/or postgraduate allergy education. Confidence in dealing with different aspect of allergy management differed between countries. The main reason for specialist referral was a perceived need for tertiary assessment (54.3%) and the main barrier for referral was the consideration that the patient’s condition could be appropriately diagnosed and treated in a primary care facility. Up to 44.7% and 55.3% of participants reported that they preferred e-Learning over traditional learning. Conclusions This study identified the specific areas of skills training and educational needs of GPs in managing allergic conditions in primary care, and provided insights possible strategies for more feasible and cost-effective approaches.
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
The aim of this survey was to explore the specific educational needs of a cohort of European GPs with regards to allergy training so that future educational initiatives may better support the delivery of allergy services in primary care. Method This study took the form of a cross-sectional observational study in which a structured electronic questionnaire was distributed to primary care providers, in eight languages, across 8 European countries between September 2019 and November 2019. Data associated with demographic parameters, professional qualifications, type of employment, level of confidence regarding competencies for diagnosis and treatment of allergic diseases, referral of patients to allergist and preferred method of learning and assessment were collected. A 5-point Likert scale was used to assess level of confidence. Exploratory analysis was carried out. Results A total of 687 responses were available for analysis, with 99.3% of responders working within Europe. 70.1% of participants were female; and 48.0% and 48.0% of participants respectively had received some undergraduate and/or postgraduate allergy education. Confidence in dealing with different aspect of allergy management differed between countries. The main reason for specialist referral was a perceived need for tertiary assessment (54.3%) and the main barrier for referral was the consideration that the patient’s condition could be appropriately diagnosed and treated in a primary care facility. Up to 44.7% and 55.3% of participants reported that they preferred e-Learning over traditional learning. Conclusions This study identified the specific areas of skills training and educational needs of GPs in managing allergic conditions in primary care, and provided insights possible strategies for more feasible and cost-effective approaches.
- Open Access
- 1 July 2021
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 14, 851-861
High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma
Purpose: Many patients with asthma still have insufficient disease control, despite the availability of effective treatment options. A substantial proportion of patients appear to rely more on short-acting beta2-agonist (SABA) rather than on anti-inflammatory maintenance treatment. The aim of this study was to describe differences in indicators of asthma symptoms and exacerbations among patients using more or less SABA than the guideline-recommended threshold of < 3 times/week. Patients and Methods: Data from Dutch respondents in the European REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey were used in this post hoc analysis. The survey included asthma patients aged 18– 50 years with at least two prescriptions for their asthma in the past two years. SABA use was categorized into two groups: < 3 (low-SABA users) or ≥ 3 (high-SABA users) times in the last week. Results: Of the 736 asthma patients, 21% did not use SABA and 19% used SABA 1 to 2 times (all low SABA users) and 60% used SABA ≥ 3 times (high SABA users) in the last week. The majority of high and low SABA users also reported using an ICS-containing treatment. Significant differences were found for all indicators related to exacerbations (p< 0.001): high SABA users more frequently used antibiotics and oral steroids, more frequently visited the emergency departments or needed an overnight hospital stay. Indicators of asthma symptoms were not significantly different between both groups. Conclusion: The majority of a Dutch asthmatic population reported high SABA use and had frequent moderate/severe exacerbations. More effective interventions are needed to change healthcare providers’ and patients’ behaviours to improve care and reduce SABA (over)use.
- 1 July 2021
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 14, 851-861
Open AccessHigh Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma
Purpose: Many patients with asthma still have insufficient disease control, despite the availability of effective treatment options. A substantial proportion of patients appear to rely more on short-acting beta2-agonist (SABA) rather than on anti-inflammatory maintenance treatment. The aim of this study was to describe differences in indicators of asthma symptoms and exacerbations among patients using more or less SABA than the guideline-recommended threshold of < 3 times/week. Patients and Methods: Data from Dutch respondents in the European REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey were used in this post hoc analysis. The survey included asthma patients aged 18– 50 years with at least two prescriptions for their asthma in the past two years. SABA use was categorized into two groups: < 3 (low-SABA users) or ≥ 3 (high-SABA users) times in the last week. Results: Of the 736 asthma patients, 21% did not use SABA and 19% used SABA 1 to 2 times (all low SABA users) and 60% used SABA ≥ 3 times (high SABA users) in the last week. The majority of high and low SABA users also reported using an ICS-containing treatment. Significant differences were found for all indicators related to exacerbations (p< 0.001): high SABA users more frequently used antibiotics and oral steroids, more frequently visited the emergency departments or needed an overnight hospital stay. Indicators of asthma symptoms were not significantly different between both groups. Conclusion: The majority of a Dutch asthmatic population reported high SABA use and had frequent moderate/severe exacerbations. More effective interventions are needed to change healthcare providers’ and patients’ behaviours to improve care and reduce SABA (over)use.
- Open Access
- 29 April 2021
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 51 (8) , 1080-1084
Aeroallergen sensitization for detecting asthma in primary care: A diagnostic test accuracy study
Click on the article title to read more.
- 29 April 2021
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 51 (8) , 1080-1084
Open AccessAeroallergen sensitization for detecting asthma in primary care: A diagnostic test accuracy study
Click on the article title to read more.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Food allergy logogram to facilitate the diagnosis of food allergy in primary care
Background: Allergy management in primary care is currently not optimal in most European countries which is attributed to educational gaps as reported by general practitioners (GPs). Aim: The aim of the logograms is to provide clarity and to facilitate the diagnostic process of 5 common allergic problems encountered in primary care (asthma, anaphylaxis, food allergy, drug allergy and urticaria). This abstract focuses on food allergy. Methods: Existing (inter)national guidelines and questionnaires on the diagnosis of food allergy were identified. The resulting food allergy logogram was based on a pragmatic primary care interpretation of existing literature. The food allergy logogram evolved during 5 in-depth interdisciplinary discussions with the international Task Force including GPs, allergy specialists, researchers and clinical fellows. Results: The food allergy logogram consists of 3 schematic flow diagrams: 1)differentiating food allergy from food intolerances, 2)determining the likelihood of food allergy, 3)risk-assessment of food allergy. If desired by the GP, more information behind the food allergy logogram is available in two layers about key terms in the food allergy logogram and background information. Conclusion: Based on existing mainly specialist guidelines, we developed a simple and pragmatic food allergy logogram for primary care in order to support GPs in making a (provisional) allergy diagnosis. Further steps are peer validation and computerization of the logograms. Ultimately, a trial should be undertaken to confirm the utility of the logograms in primary care. This may in future facilitate improved integrated care in allergy and improvement of both patient outcomes and experience of services.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Food allergy logogram to facilitate the diagnosis of food allergy in primary care
Background: Allergy management in primary care is currently not optimal in most European countries which is attributed to educational gaps as reported by general practitioners (GPs). Aim: The aim of the logograms is to provide clarity and to facilitate the diagnostic process of 5 common allergic problems encountered in primary care (asthma, anaphylaxis, food allergy, drug allergy and urticaria). This abstract focuses on food allergy. Methods: Existing (inter)national guidelines and questionnaires on the diagnosis of food allergy were identified. The resulting food allergy logogram was based on a pragmatic primary care interpretation of existing literature. The food allergy logogram evolved during 5 in-depth interdisciplinary discussions with the international Task Force including GPs, allergy specialists, researchers and clinical fellows. Results: The food allergy logogram consists of 3 schematic flow diagrams: 1)differentiating food allergy from food intolerances, 2)determining the likelihood of food allergy, 3)risk-assessment of food allergy. If desired by the GP, more information behind the food allergy logogram is available in two layers about key terms in the food allergy logogram and background information. Conclusion: Based on existing mainly specialist guidelines, we developed a simple and pragmatic food allergy logogram for primary care in order to support GPs in making a (provisional) allergy diagnosis. Further steps are peer validation and computerization of the logograms. Ultimately, a trial should be undertaken to confirm the utility of the logograms in primary care. This may in future facilitate improved integrated care in allergy and improvement of both patient outcomes and experience of services.
- Open Access
- 1 July 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1601-1611
Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care
Purpose: Primary care COPD guidelines indicate that COPD patients with asthma characteristics should be treated as having asthma. This study aims to describe the prevalence of asthma characteristics in patients with a pulmonologist-confirmed working diagnosis of COPD or ACO. Patients and Methods: This retrospective cross-sectional study used real-life data (collected between 2007 and 2017) from a Dutch asthma/COPD-service, a structured web-based system in which pulmonologists support general practitioners in their diagnosis of patients with suspicion of obstructive lung disease. The prevalence of asthma characteristics (history of asthma, atopy, symptoms, and reversibility) and blood eosinophil (Eos) counts were assessed in patients with a working diagnosis of COPD or ACO. Results: Of the 14,141 patients, ≥ 40 years in the dataset, 4475 (31.6%) were diagnosed with asthma, 3532 (25.0%) with COPD, and 1276 (9.0%) with ACO. Asthma characteristics were present in 65.6% (n=1956) of the COPD and 90.9% (n=1059) of the ACO patients. Eos counts of ≥ 300 cells per μL were found in 35.7% (n=924) of the COPD patients and 35.3% (n=341) of the ACO patients. Conclusion: In this group of COPD and ACO patients remotely diagnosed by pulmonologists, a substantial proportion would be considered to have asthma characteristics according to the guidelines. This may explain the high number of inhaled corticosteroid (ICS) prescriptions found in primary care COPD patients. Prospective studies are necessary to identify patients who may or may not benefit from ICS containing treatment. Hence, personalized care in primary care can be optimized.
- 1 July 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1601-1611
Open AccessPrevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care
Purpose: Primary care COPD guidelines indicate that COPD patients with asthma characteristics should be treated as having asthma. This study aims to describe the prevalence of asthma characteristics in patients with a pulmonologist-confirmed working diagnosis of COPD or ACO. Patients and Methods: This retrospective cross-sectional study used real-life data (collected between 2007 and 2017) from a Dutch asthma/COPD-service, a structured web-based system in which pulmonologists support general practitioners in their diagnosis of patients with suspicion of obstructive lung disease. The prevalence of asthma characteristics (history of asthma, atopy, symptoms, and reversibility) and blood eosinophil (Eos) counts were assessed in patients with a working diagnosis of COPD or ACO. Results: Of the 14,141 patients, ≥ 40 years in the dataset, 4475 (31.6%) were diagnosed with asthma, 3532 (25.0%) with COPD, and 1276 (9.0%) with ACO. Asthma characteristics were present in 65.6% (n=1956) of the COPD and 90.9% (n=1059) of the ACO patients. Eos counts of ≥ 300 cells per μL were found in 35.7% (n=924) of the COPD patients and 35.3% (n=341) of the ACO patients. Conclusion: In this group of COPD and ACO patients remotely diagnosed by pulmonologists, a substantial proportion would be considered to have asthma characteristics according to the guidelines. This may explain the high number of inhaled corticosteroid (ICS) prescriptions found in primary care COPD patients. Prospective studies are necessary to identify patients who may or may not benefit from ICS containing treatment. Hence, personalized care in primary care can be optimized.